ArticleActa pharmaceutica Sinica. B2023

Erratum: Author correction to "YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer" [Acta Pharmaceutica Sinica B 12 (2022) 2845-2858].

Fangfang Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.